Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
Clinical trial NCT07001618 · RECRUITING
Trial details
- NCT number
- NCT07001618
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-17
- Primary completion
- 2030-09-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.